Mepacrine hydrochloride

盐酸米帕林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMepacrine hydrochloride
Drug Alias Namemepacrina盐酸阿的平米帕林盐酸盐Quinacrine hydrochloridemepacrinum +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSecretory phospholipase A2 inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complexSecretory phospholipase A2
Therapy Area/IndicationsLupus Erythematosus, SystemicProstatic NeoplasmsCarcinoma, Renal Cell +[7] 
Global Approved IndicationsLupus Erythematosus, SystemicMalariaLeishmaniasis +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1932/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesUniversity Of California San FranciscoCleveland Biolabs Inc
Active IndicationsLupus Erythematosus, SystemicMalariaLeishmaniasis +[4] 
Inactive IndicationsProstatic NeoplasmsCarcinoma, Renal CellCreutzfeldt-Jakob Syndrome

Other Information

ATC CodeP01AX05
Related LinksWikipediaDrugBankKEGG